LABQARE: what changed
Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
LABQARE
Largest movements
- Cash -€944
down €944 (-47.5%), from €1,990 to €1,045
mainly Net result for the year (-€1,348) and Other debts (-€200)
- Receivables within one year +€22
new in 2025: €22
- Profit (loss) carried forward -€1,348
down €1,348 (-28.3%), from -€4,756 to -€6,104
- Trade debts +€625
new in 2025: €625
- Other debts -€200
down €200 (-18.2%), from €1,101 to €901
- Gross operating margin +€250
up €250 (+17.1%), from -€1,463 to -€1,213
- Financial charges +€135
new in 2025: €135
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €1,990 | €1,067 | -€922 | -46.4% |
| Current assets | 29/58 | €1,990 | €1,067 | -€922 | -46.4% |
| Amounts receivable within one year | 40/41 | - | €22 | +€22 | |
| Other amounts receivable | 41 | - | €22 | +€22 | |
| Cash at bank and in hand | 54/58 | €1,990 | €1,045 | -€944 | -47.5% |
| Total equity and liabilities | 10/49 | €1,990 | €1,067 | -€922 | -46.4% |
| Equity | 10/15 | €889 | -€459 | -€1,348 | |
| Contributions | 10/11 | €5,645 | €5,645 | = | 0.0% |
| Profit (loss) carried forward | 14 | -€4,756 | -€6,104 | -€1,348 | -28.3% |
| Amounts payable | 17/49 | €1,101 | €1,526 | +€425 | +38.6% |
| Amounts payable within one year | 42/48 | €1,101 | €1,526 | +€425 | +38.6% |
| Trade debts | 44 | - | €625 | +€625 | |
| Suppliers | 440/4 | - | €625 | +€625 | |
| Other amounts payable | 47/48 | €1,101 | €901 | -€200 | -18.2% |
| Gross operating margin | 9900 | -€1,463 | -€1,213 | +€250 | +17.1% |
| Operating profit (loss) | 9901 | -€1,463 | -€1,213 | +€250 | +17.1% |
| Financial charges | 65/66B | - | €135 | +€135 | |
| Recurring financial charges | 65 | - | €135 | +€135 | |
| Profit (loss) for the period before taxes | 9903 | -€1,463 | -€1,348 | +€115 | +7.9% |
| Profit (loss) for the period | 9904 | -€1,463 | -€1,348 | +€115 | +7.9% |
| Profit (loss) for the period to be appropriated | 9905 | -€1,463 | -€1,348 | +€115 | +7.9% |
Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 1 October 2026 via checked.be.